olmesartan has been researched along with Diabetes Mellitus in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calia, K; Ding, X; Gelperin, K; Graham, DJ; Kelman, JA; Levenson, M; MaCurdy, TE; McKean, S; Worrall, C; Zhou, EH | 1 |
| Gelperin, K; Graham, DJ; Hsueh, YH; Levenson, MS; Rose, M; Zhou, EH | 1 |
| Etminan, M; Eurich, DT; Lin, M; Padwal, R | 1 |
| Camelo Castillo, W; Delaney, JA; Stürmer, T | 1 |
| Farragut, KM; Garner, MK; Hara, T; Imanishi, M; Kamiyama, M; Kobori, H; Konishi, Y; Morikawa, T; Nishiyama, A; Sofue, T | 1 |
| Chrysant, SG; Heyrman, R; Karki, S; Lee, J; Melino, M | 1 |
| Maa, JF; Punzi, H; Shojaee, A; Waverczak, WF | 1 |
| Asai, S; Nakayama, T; Nishida, Y; Soma, M; Takahashi, Y | 1 |
| Biskupiak, J; Qian, C; Quah, R; Ram, CV; Ramaswamy, K; Russo, PA; Ryan, A | 1 |
| Pugsley, MK | 1 |
1 review(s) available for olmesartan and Diabetes Mellitus
| Article | Year |
|---|---|
The angiotensin-II (AT-II) receptor blocker olmesartan reduces renal damage in animal models of hypertension and diabetes.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Desoxycorticosterone; Diabetes Mellitus; Diabetic Nephropathies; Hypertension; Imidazoles; Kidney; Rats; Rats, Inbred SHR; Rats, Zucker; Tetrazoles | 2005 |
1 trial(s) available for olmesartan and Diabetes Mellitus
| Article | Year |
|---|---|
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension.
Topics: Age Factors; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Black or African American; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Obesity; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; United States; Vasodilator Agents | 2010 |
8 other study(ies) available for olmesartan and Diabetes Mellitus
| Article | Year |
|---|---|
Cardiovascular and mortality risk in elderly Medicare beneficiaries treated with olmesartan versus other angiotensin receptor blockers.
Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Imidazoles; Male; Medicare; Practice Patterns, Physicians'; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Tetrazoles; Time Factors; United States | 2014 |
Risk of acute myocardial infarction, stroke, or death in patients initiating olmesartan or other angiotensin receptor blockers - a cohort study using the Clinical Practice Research Datalink.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Cohort Studies; Databases, Factual; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Regression Analysis; Risk; Stroke; Tetrazoles | 2014 |
Comparative effectiveness of olmesartan and other angiotensin receptor blockers in diabetes mellitus: retrospective cohort study.
Topics: Adult; Angiotensin Receptor Antagonists; Cardiovascular Diseases; Cohort Studies; Comorbidity; Diabetes Mellitus; Female; Gastrointestinal Diseases; Hospitalization; Humans; Hypertension; Imidazoles; Male; Middle Aged; Proportional Hazards Models; Registries; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Survival Rate; Tetrazoles; Treatment Outcome; United States | 2014 |
The challenges of comparing results between placebo controlled randomized trials and non-experimental new user, active comparator cohort studies: the example of olmesartan.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Imidazoles; Male; Myocardial Infarction; Stroke; Tetrazoles | 2014 |
Detailed localization of augmented angiotensinogen mRNA and protein in proximal tubule segments of diabetic kidneys in rats and humans.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Diabetes Mellitus; DNA Primers; Fluorescent Antibody Technique; Humans; Imidazoles; Immunohistochemistry; In Situ Hybridization, Fluorescence; Kidney Tubules, Proximal; Male; Rats; Rats, Inbred OLETF; RNA, Messenger; Species Specificity; Tetrazoles; Vasodilator Agents | 2014 |
Efficacy of amlodipine and olmesartan medoxomil in hypertensive patients with diabetes and obesity.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Obesity; Prospective Studies; Tetrazoles | 2011 |
Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study.
Topics: Aged; Angiotensin II Type 2 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Urea Nitrogen; Cholesterol; Cholesterol, LDL; Cohort Studies; Creatinine; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Imidazoles; Kidney; Lipid Metabolism; Male; Middle Aged; Potassium; Retrospective Studies; Tetrazoles; Triglycerides | 2011 |
Blood pressure outcomes in patients receiving angiotensin II receptor blockers in primary care: a comparative effectiveness analysis from electronic medical record data.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Black or African American; Blood Pressure; Diabetes Mellitus; Electronic Health Records; Female; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Obesity; Primary Health Care; Retrospective Studies; Tetrazoles; Treatment Outcome; Valine; Valsartan; White People; Young Adult | 2011 |